Legal
Drugmakers Seek to Intervene in 340B Rebate Pilot Lawsuit
Pharmaceutical manufacturers have asked to intervene in litigation brought by hospitals challenging a rebate pilot program in the 340B drug discount program. Hospitals are seeking to halt the pilot, while drugmakers want standing to defend it in court. The filing signals manufacturers view the outcome as material to how 340B rebates are administered going forward. No ruling on the intervention motion or the underlying challenge has been reported yet.
Why it mattersCovered entities, including safety-net hospitals and the health plans that serve Medicaid-eligible populations through them, face uncertainty over 340B drug pricing and rebate mechanics until the litigation resolves.